Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices by ETHZilla Corporation and its officers or directors [1] Group 1: Company Financials and Operations - On December 19, 2025, ETHZilla disclosed the sale of approximately 24,291 Ether (ETH) for a total of $74.5 million, intending to use the funds primarily to redeem outstanding senior secured convertible notes [3] - The company plans to explore various capital raising strategies, including ETH sales and equity offerings, to support its business plans, particularly the tokenization of real-world assets [3] - On December 22, 2025, ETHZilla indicated that its future value would be driven by revenue and cash flow growth from its RWA tokenization business [3] Group 2: Market Reaction - Following the announcements, ETHZilla's stock price decreased by $0.60 per share, or 8.70%, closing at $6.30 per share on December 22, 2025 [3]

Core Viewpoint - An investigation has been announced regarding Bgin Blockchain Limited for potential violations of federal securities laws, indicating possible legal issues for the company and its investors [1]. Company Summary - Bgin Blockchain Limited (NASDAQ: BGIN) is under scrutiny for its compliance with federal securities regulations, which may affect its reputation and financial standing [1]. - Investors who have incurred losses in Bgin Blockchain Limited are encouraged to contact legal representatives to explore options for recovering their losses [1].

Core Viewpoint - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving RH, focusing on whether RH and its executives made false or misleading statements or failed to disclose material information to investors [1] Company Overview - RH operates as a high-end home furnishings retailer and lifestyle brand [2] Financial Performance - On April 2, 2025, RH reported its fourth quarter and fiscal year 2024 financial results, with earnings per share of $1.58 on revenues of $812 million, which was below RH's previous guidance of $1.92 earnings per share and $830 million in revenue [3] - Following the financial results announcement, RH's stock price fell by more than 40% [3] Legal Context - Robbins Geller Rudman & Dowd LLP is recognized as a leading law firm in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in securities-related class action cases in 2024 [4] - The firm has been ranked 1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors [4]

Core Viewpoint - The Law Offices of Frank R. Cruz is investigating Bgin Blockchain Limited for potential violations of federal securities laws following its Initial Public Offering on October 21, 2025 [1] Group 1 - The investigation is on behalf of investors who may have lost money on Bgin Blockchain Limited [1] - The company is listed on NASDAQ under the ticker symbol BGIN [1]

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3]. Group 2: Company Performance and Stock Impact - Alexandria Real Estate, a real estate investment trust focused on life science industries, reported lower occupancy rates and slower leasing activity, leading to a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property [4][5]. - On October 27, 2025, the company announced disappointing 3Q 2025 results and reduced guidance for the fiscal year, causing its stock to drop by $14.93 per share, or over 19%, from $77.87 to $62.94 [6]. - The company indicated that the Long Island City property was not a viable life science destination that could scale, contributing to the impairment charges [6]. Group 3: Legal Representation - Bleichmar Fonti & Auld LLP, the law firm representing the plaintiffs, has a strong track record in securities class actions and has recovered significant amounts for investors in previous cases [8]. - The firm operates on a contingency fee basis, meaning there are no upfront costs for shareholders [7].

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - Inspire Medical Systems develops and manufactures an implantable medical device for the treatment of sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [4]. Allegations and Issues - The lawsuit claims that Inspire misled investors by assuring them that all necessary steps were taken for the launch of Inspire V, which was supposed to meet high demand [5]. - Contrary to these assurances, Inspire allegedly failed to prepare clinicians and payors adequately, leading to significant delays in the device's adoption and weak demand due to excess inventory of older devices [6]. Stock Performance and Impact - On August 4, 2025, Inspire disclosed that the launch of Inspire V would face an "elongated timeframe," resulting in a reduction of its 2025 earnings per share guidance by over 80% [7]. - The stock price dropped by $42.04 per share, or more than 32%, from $129.95 on August 4, 2025, to $87.91 on August 5, 2025, following this announcement [8].

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. and its senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Stride, Inc. is an education technology company that provides an online platform to students across the U.S. [4]. Allegations and Impact - The lawsuit alleges that Stride inflated enrollment numbers by retaining "ghost students," ignored compliance requirements, and had a poor customer experience leading to higher withdrawal rates and lower conversion rates [4]. - Stride's stock price dropped significantly due to these allegations, falling by $18.60 (over 11%) on September 15, 2025, and by $83.48 (over 54%) on October 29, 2025, following admissions of poor customer experience [5][6]. Legal Proceedings - Investors have until January 12, 2026, to request to lead the case in the U.S. District Court for the Eastern District of Virginia, under the case caption MacMahon v. Stride, Inc., et al. [3]. Financial Implications - Stride estimated that the issues led to approximately 10,000-15,000 fewer enrollments, resulting in a muted outlook compared to previous years [6].

Company Overview - Fermi Inc. is developing a large electric generation campus for AI data centers and conducted its initial public offering (IPO) on September 30, 2025, issuing approximately 32.5 million shares at an offering price of $21.00 per share [3]. Key Developments - The IPO's offering document indicated that Fermi entered into a letter of intent with an investment grade-rated tenant to lease a portion of the Project Matador Site for an initial lease term of twenty years, with four renewal terms of five years each [3]. - In November 2025, Fermi announced that the First Tenant agreed to advance up to $150 million to fund construction costs through an Advance in Aid of Construction Agreement (AICA) [3]. Recent Revelation - On December 12, 2025, Fermi disclosed that the First Tenant notified them of the termination of the AICA, although negotiations for a lease agreement were still ongoing [4]. - Following this announcement, Fermi's stock price fell more than 33%, closing at $10.09 per share, significantly below the IPO price [4].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - Alexandria Real Estate reported disappointing results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on October 27-28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to a property in Long Island City, New York, indicating lower occupancy rates and slower leasing activity [5][6]. Legal Proceedings - Investors have until January 26, 2026, to request to lead the class action case, which is pending in the U.S. District Court for the Central District of California [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3].

Core Viewpoint - Jefferies Financial Group Inc. and its trade finance arm Point Bonita Capital are under investigation for potential violations of federal securities laws following a probe by the SEC related to their exposure to First Brands Group, which filed for bankruptcy in September 2025 [1][4]. Group 1: Company Overview - Jefferies is an investment banking and capital markets firm, while Point Bonita Capital is its trade finance division [2]. - Both firms were closely associated with First Brands Group, an auto parts supplier that declared bankruptcy with $12 billion in debt [2][4]. Group 2: Financial Exposure - On October 8, 2025, Jefferies disclosed that it and Point Bonita had approximately $715 million in exposure to First Brands' receivables, accounting for about 25% of Point Bonita's trade finance portfolio [3]. - Following this announcement, Jefferies' stock price dropped by $4.66 per share, or approximately 8%, from $59.10 on October 7, 2025, to $54.44 on October 8, 2025 [3]. Group 3: SEC Investigation Details - The SEC is investigating whether Jefferies provided sufficient information to investors regarding their exposure to the auto business, particularly in light of First Brands' bankruptcy [4]. - The investigation also includes scrutiny of internal controls and potential conflicts of interest within Jefferies and Point Bonita [4][5]. Group 4: Legal Implications - Bleichmar Fonti & Auld LLP is investigating whether Jefferies and/or Point Bonita made materially false and misleading statements to investors concerning their significant exposure to First Brands and the ongoing SEC investigation [5].